title: Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
authors.affiliation: School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA; Albany College of Pharmacy & Health Sciences, Albany, New York, USA; PGY2 Pain & Palliative Care Pharmacy Residency, Stratton VA Medical Center, Albany, New York, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Fudin
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Atkinson
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D010098:Oxycodone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D059408:Pain Management / Q000379:methods / Q000639:trends*; D010597:Pharmacogenetics / Q000379:methods / Q000639:trends*; D057285:Precision Medicine / Q000379:methods / Q000639:trends*; D012306:Risk
chemical_list: D000701:Analgesics, Opioid; D010098:Oxycodone